The conflict of interest point is worth expanding on: Janoshik's model: You pay, they test, they report. Simple. No relationship with vendors. No ratings to maintain. No database to monetize. The incentive structure is clean — their only product is accurate testing. Finnrick's model: More complex. They offer free tests (funded how?), maintain vendor ratings (who decides the criteria?), and build a database (who has access?). They also offer paid consulting to vendors who want to improve their quality. > When a testing service also consults for vendors, there's an inherent tension. Can they objectively rate a vendor they're also advising? I want to be clear: I'm NOT saying Finnrick is compromised. I'm saying the business model has more potential pressure points than Janoshik's. Being aware of this isn't paranoia — it's good critical thinking. The best approach: trust but verify. Use both services. Cross-reference results. If they consistently agree, both are reliable. If they diverge, investigate why.

This is the kind of nuanced discussion I love seeing on this forum. Let me share the mod team's perspective: CompoundTalk's position on both services: - We recognize both Janoshik and Finnrick as legitimate analytical testing services - We accept results from either service in our Vendor Reviews section - We note which service performed each test in our database - We do NOT exclusively endorse either service What we've observed: - In 23 cases where the same vendor/batch was tested by both services, results agreed within ±3% on purity — which is within normal analytical variation - Both services have correctly identified contaminated, misdosed, and mislabeled products - Both services have been responsive to community inquiries and verification requests Our recommendation: Use whichever service is most accessible and affordable for you. If you can use both, even better. The more independent data points, the stronger the community's knowledge base.

Let me do a practical side-by-side for a typical use case — testing tirzepatide from a new vendor: | Factor | Janoshik | Finnrick | |--------|----------|----------| | Cost (ID + Purity) | ~$180 | Free (if eligible) or ~$165 | | Shipping from US | $15-20 international | ~$10 domestic | | Ship time to lab | 10-14 days | 2-4 days | | Processing time | 5-10 business days | 7-12 business days | | Total turnaround | ~3-4 weeks | ~2-3 weeks | | Report detail | Very detailed chromatograms | Detailed + vendor rating context | | Identity confirmation | Yes (RT matching) | Yes (RT matching) | | Quantitative | Extra $70 | Included in free test (estimate) | | Sterility | Extra $200 | Extra $150 | | Payment options | Crypto, bank transfer | Crypto, card, bank transfer | For a US-based member testing an eligible peptide from a new vendor, Finnrick is objectively the better deal — potentially free, faster shipping, includes quantitative estimate. But Janoshik remains the gold standard for comprehensive paid analysis. 📋

This is exactly the comparison I needed. I think I'm going to try Finnrick first since my vendor is new and I should qualify for the free test. If anything comes back questionable, I'll send a second sample to Janoshik for independent verification.

That's a smart approach and honestly what I'd recommend to most US members. Use Finnrick as your first line of testing (especially with the free program) and Janoshik as your verification/comprehensive option. Some final thoughts on this comparison: The best thing about having two services: They keep each other honest. If Finnrick's results consistently diverge from Janoshik's, the community would notice instantly. If Janoshik started declining in quality, Finnrick provides an alternative. Competition and redundancy in testing infrastructure benefits everyone. What I'd like to see in the future: - More testing services entering the space (competition is good) - Standardized reporting formats so results from different labs are easier to compare - A community-maintained database that aggregates results from ALL testing services - Cheaper testing overall as the market matures We're in a much better place now than we were even 2 years ago. Having two credible, independent testing services is a luxury this community didn't always have. Use them. 🙌